Microbot Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Microbot Medical
MBOT Stock  USD 0.93  0.01  1.09%   
Microbot Medical financial statements provide useful quarterly and yearly information to potential Microbot Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Microbot Medical financial statements helps investors assess Microbot Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Microbot Medical's valuation are summarized below:
Market Capitalization
15.6 M
Earnings Share
(0.79)
There are currently one hundred twenty fundamental ratios for Microbot Medical that can be evaluated and compared over time across peers in the industry. All traders should check Microbot Medical's last-minute fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 28.5 M in 2024, whereas Market Cap is likely to drop slightly above 15.9 M in 2024.

Microbot Medical Total Revenue

0.0

Check Microbot Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbot Medical's main balance sheet or income statement drivers, such as Interest Expense of 158.5 M, Total Revenue of 0.0 or Other Operating Expenses of 14.3 M, as well as many indicators such as Price To Sales Ratio of 302, Dividend Yield of 58.41 or PTB Ratio of 3.9. Microbot financial statements analysis is a perfect complement when working with Microbot Medical Valuation or Volatility modules.
  
Check out the analysis of Microbot Medical Correlation against competitors.
For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Microbot Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets7.9 M8.3 M19.6 M
Slightly volatile
Short and Long Term Debt Total219.4 K231 K3 M
Slightly volatile
Other Current Liabilities2.6 M3.2 M3 M
Slightly volatile
Total Current Liabilities4.8 M3.8 M4.5 M
Slightly volatile
Property Plant And Equipment Net385.7 K406 K1.7 M
Slightly volatile
Accounts Payable489.2 K357 K371.5 K
Slightly volatile
Cash2.3 M2.5 M12.8 M
Slightly volatile
Non Current Assets Total385.7 K406 K2.9 M
Slightly volatile
Cash And Short Term Investments6.1 M6.4 M15.5 M
Slightly volatile
Net Receivables1.4 M1.3 M360.9 K
Slightly volatile
Common Stock Shares Outstanding10.7 M10.2 M3.5 M
Slightly volatile
Liabilities And Stockholders Equity7.9 M8.3 M19.6 M
Slightly volatile
Non Current Liabilities Total38 K40 K4.6 M
Slightly volatile
Other Current Assets3.2 M1.6 M1.3 M
Pretty Stable
Other Stockholder Equity88.1 M83.9 M170.1 M
Slightly volatile
Total Liabilities3.6 M3.8 M9 M
Slightly volatile
Total Current Assets7.5 M7.9 M16.8 M
Slightly volatile
Short Term Debt181.4 K191 K826.8 K
Slightly volatile
Property Plant And Equipment Gross854 K899 K2.4 M
Slightly volatile
Common Stock Total Equity61.5664.8344.1 K
Slightly volatile
Common Stock112.1 K118 K374.4 K
Slightly volatile
Current Deferred Revenue1.4 M927.9 K2.5 M
Slightly volatile
Long Term Debt Total83 K87.4 K2 M
Slightly volatile
Capital Surpluse58.6 M61.7 M187.6 M
Slightly volatile
Deferred Long Term Liabilities6.8 K7.2 K547.3 K
Slightly volatile
Non Current Liabilities Other535.2 K563.4 K2.5 M
Slightly volatile
Property Plant Equipment1.2 M650.7 K1.4 M
Slightly volatile
Capital Lease Obligations432.7 K231 K422 K
Slightly volatile
Other Liabilities6.8 K7.2 K1.1 M
Slightly volatile
Short and Long Term Debt65 K68.4 K1.6 M
Slightly volatile
Warrants400 K450 K490 K
Slightly volatile
Net Invested Capital4.3 M4.5 M11.2 M
Very volatile
Net Working Capital3.9 M4.1 M11.2 M
Very volatile
Capital Stock81.6 K118 K51.6 K
Slightly volatile

Microbot Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses14.3 M9.9 M16.3 M
Slightly volatile
Total Operating Expenses18.8 M9.9 M16.2 M
Slightly volatile
Research Development9.5 M5.7 M10.6 M
Slightly volatile
Selling General Administrative3.9 M4.1 M626.7 M
Pretty Stable
Selling And Marketing Expenses182192905.5 M
Slightly volatile
Non Recurring524 K589.5 K641.9 K
Slightly volatile
Interest Income222.6 K212 K54.4 K
Slightly volatile
Reconciled Depreciation80 K104 K49.1 K
Slightly volatile

Microbot Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow2.4 M2.5 M12.6 M
Pretty Stable
Depreciation100.7 K106 K447.5 K
Slightly volatile
Capital Expenditures31.4 K33 K569.3 K
Slightly volatile
End Period Cash Flow2.4 M2.5 M13.3 M
Slightly volatile
Stock Based Compensation1.3 M1.4 M84.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio302383291
Slightly volatile
Dividend Yield58.4161.4976.0316
Slightly volatile
Days Sales Outstanding77.3581.4296.9521
Pretty Stable
Average Payables708.7 K1.1 M852.1 K
Pretty Stable
Stock Based Compensation To Revenue39.6341.72128
Slightly volatile
Capex To Depreciation0.30.31131.5842
Pretty Stable
Payables Turnover0.280.29691.0642
Slightly volatile
Sales General And Administrative To Revenue75.4 K71.8 K52.4 K
Slightly volatile
Research And Ddevelopement To Revenue219209157
Slightly volatile
Capex To Revenue8.518.116.3446
Slightly volatile
Cash Per Share0.590.6262.9 K
Slightly volatile
Days Payables Outstanding8371.2 K1.5 K
Very volatile
Income Quality0.950.79450.7782
Very volatile
Intangibles To Total Assets0.00190.0020.0302
Slightly volatile
Net Debt To EBITDA0.20.21041.1323
Very volatile
Current Ratio1.992.09226.2198
Very volatile
Receivables Turnover4.414.643.8158
Slightly volatile
Graham Number3.073.23339.2 K
Slightly volatile
Capex Per Share0.00310.0032137
Slightly volatile
Average Receivables332.5 K454.8 K443 K
Slightly volatile
Revenue Per Share1.751.84106
Slightly volatile
Interest Debt Per Share0.03210.033817.7 K
Slightly volatile
Debt To Assets0.00610.006415.6378
Slightly volatile
Days Of Payables Outstanding8371.2 K1.5 K
Very volatile
Long Term Debt To Capitalization0.03670.03860.4272
Pretty Stable
Total Debt To Capitalization0.00650.00690.5584
Pretty Stable
Quick Ratio1.992.09226.243
Very volatile
Cash Ratio0.620.65194.9849
Very volatile
Days Of Sales Outstanding77.3581.4296.9521
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.221.00391.0529
Very volatile
Fixed Asset Turnover0.02450.02580.1679
Slightly volatile
Debt Ratio0.00610.006415.6378
Slightly volatile
Price Sales Ratio302383291
Slightly volatile
Asset Turnover0.0060.00630.016
Slightly volatile

Microbot Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap15.9 M16.7 M34.6 M
Pretty Stable

Microbot Fundamental Market Drivers

Cash And Short Term Investments6.4 M

Microbot Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
15th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Microbot Medical Financial Statements

Microbot Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Microbot Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Microbot Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Microbot Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue927.9 K1.4 M
Cost Of Revenue106 K100.7 K
Stock Based Compensation To Revenue 41.72  39.63 
Sales General And Administrative To Revenue71.8 K75.4 K
Research And Ddevelopement To Revenue 208.55  218.97 
Capex To Revenue 8.11  8.51 
Revenue Per Share 1.84  1.75 
Ebit Per Revenue(360.92)(342.88)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY